94 related articles for article (PubMed ID: 19726084)
1. The TCL1 mouse as a model for chronic lymphocytic leukemia.
Hamblin TJ
Leuk Res; 2010 Feb; 34(2):135-6. PubMed ID: 19726084
[TBL] [Abstract][Full Text] [Related]
2. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
[TBL] [Abstract][Full Text] [Related]
3. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
4. Animal models for chronic lymphocytic leukemia.
Pekarsky Y; Zanesi N; Aqeilan RI; Croce CM
J Cell Biochem; 2007 Apr; 100(5):1109-18. PubMed ID: 17131382
[TBL] [Abstract][Full Text] [Related]
5. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia.
Bresin A; D'Abundo L; Narducci MG; Fiorenza MT; Croce CM; Negrini M; Russo G
Cell Death Dis; 2016 Jan; 7(1):e2071. PubMed ID: 26821067
[TBL] [Abstract][Full Text] [Related]
6. Tcl1 as a model for lymphomagenesis.
Pekarsky Y; Zanesi N; Aqeilan R; Croce CM
Hematol Oncol Clin North Am; 2004 Aug; 18(4):863-79, ix. PubMed ID: 15325703
[TBL] [Abstract][Full Text] [Related]
7. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.
Bichi R; Shinton SA; Martin ES; Koval A; Calin GA; Cesari R; Russo G; Hardy RR; Croce CM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6955-60. PubMed ID: 12011454
[TBL] [Abstract][Full Text] [Related]
8. Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.
Hofbauer JP; Heyder C; Denk U; Kocher T; Holler C; Trapin D; Asslaber D; Tinhofer I; Greil R; Egle A
Leukemia; 2011 Sep; 25(9):1452-8. PubMed ID: 21606964
[TBL] [Abstract][Full Text] [Related]
9. The murine Tcl1 oncogene: embryonic and lymphoid cell expression.
Narducci MG; Virgilio L; Engiles JB; Buchberg AM; Billips L; Facchiano A; Croce CM; Russo G; Rothstein JL
Oncogene; 1997 Aug; 15(8):919-26. PubMed ID: 9285687
[TBL] [Abstract][Full Text] [Related]
10. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
[TBL] [Abstract][Full Text] [Related]
11. TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia.
Szenes E; Härzschel A; Decker S; Tissino E; Pischeli J; Gutjahr JC; Kissel S; Pennisi S; Höpner JP; Egle A; Zaborsky N; Dierks C; Follo M; Chigaev A; Zucchetto A; Greil R; Gattei V; Hartmann TN
Leukemia; 2020 Sep; 34(9):2498-2502. PubMed ID: 32086446
[No Abstract] [Full Text] [Related]
12. The role of TCL1 in human T-cell leukemia.
Pekarsky Y; Hallas C; Croce CM
Oncogene; 2001 Sep; 20(40):5638-43. PubMed ID: 11607815
[TBL] [Abstract][Full Text] [Related]
13. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
Calin GA; Pekarsky Y; Croce CM
Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
[TBL] [Abstract][Full Text] [Related]
14. Role of TCL1 and ALL1 in human leukemias and development.
Croce CM
Cancer Res; 1999 Apr; 59(7 Suppl):1778s-1783s. PubMed ID: 10197596
[TBL] [Abstract][Full Text] [Related]
15. Eμ-TCL1 adoptive transfer mouse model of chronic lymphocytic leukemia.
Fernandez Botana I; Gonder S; Klapp V; Moussay E; Paggetti J
Methods Cell Biol; 2024; 188():109-129. PubMed ID: 38880520
[TBL] [Abstract][Full Text] [Related]
16. E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction.
Gorgun G; Ramsay AG; Holderried TA; Zahrieh D; Le Dieu R; Liu F; Quackenbush J; Croce CM; Gribben JG
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6250-5. PubMed ID: 19332800
[TBL] [Abstract][Full Text] [Related]
17. The NZB mouse as a model for chronic lymphocytic leukemia.
Phillips JA; Mehta K; Fernandez C; Raveché ES
Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
[TBL] [Abstract][Full Text] [Related]
18. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression.
Enzler T; Kater AP; Zhang W; Widhopf GF; Chuang HY; Lee J; Avery E; Croce CM; Karin M; Kipps TJ
Blood; 2009 Nov; 114(20):4469-76. PubMed ID: 19755673
[TBL] [Abstract][Full Text] [Related]
20. The long journey of TCL1 transgenic mice: lessons learned in the last 15 years.
Pekarsky Y; Drusco A; Kumchala P; Croce CM; Zanesi N
Gene Expr; 2015; 16(3):129-35. PubMed ID: 25700368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
